Adicet Bio, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 0.70%349.020.0%$7035.16m
BNTXBioNTech SE -0.34%339.060.0%$1237.65m
SNSSSunesis Pharmaceuticals, Inc. -2.77%10.530.7%$736.09m
NVAXNovavax, Inc. -1.34%180.2779.8%$644.82m
AMGNAmgen, Inc. 0.99%242.161.3%$499.91m
BIIBBiogen, Inc. -0.82%328.981.7%$441.98m
VRTXVertex Pharmaceuticals, Inc. 0.60%199.511.9%$419.97m
GILDGilead Sciences, Inc. 0.81%68.911.0%$407.44m
REGNRegeneron Pharmaceuticals, Inc. -0.53%574.072.7%$314.37m
ILMNIllumina, Inc. 0.21%494.003.5%$256.83m
NTLAIntellia Therapeutics, Inc. -2.63%132.992.3%$189.22m
CRSPCRISPR Therapeutics AG -2.40%119.400.6%$135.01m
SGENSeagen Inc. 0.10%154.405.8%$128.68m
EXASEXACT Sciences Corp. -3.20%104.9318.1%$121.89m
BGNEBeiGene Ltd. -0.80%324.801.4%$120.99m

Company Profile

Adicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.